Related Experiment Video

Updated: Jun 8, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

E2F1 inhibits MDM2 expression in a p53-dependent manner

Xu Tian1, Youjun Chen, Wanglai Hu

  • 1Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China.

Cellular Signalling
|September 15, 2010
PubMed

Insights

E2F1 suppresses MDM2 expression through a p53-dependent mechanism, impacting the MDM2-p53 pathway and promoting apoptosis. This regulation is crucial following DNA damage.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cancer Research

Background:

  • MDM2 expression is known to be downregulated by E2F1, but the underlying mechanism remains unclear.
  • The MDM2-p53 pathway is a critical regulator of cell cycle and apoptosis.

Purpose of the Study:

  • To elucidate the mechanism by which E2F1 downregulates MDM2 expression.
  • To investigate the role of p53 in E2F1-mediated inhibition of MDM2.
  • To understand the functional consequences of E2F1-MDM2 interaction in apoptosis.

Main Methods:

  • Reporter assays to assess MDM2 promoter activity.
  • Western blotting to detect protein levels of E2F1, p53, and MDM2.
  • siRNA-mediated knockdown of p53.
  • Overexpression of p53 in p53-deficient cells.
  • DNA damage induction using appropriate stimuli.

Main Results:

  • E2F1 inhibits MDM2 promoter activity, independent of direct binding to the promoter.
  • This inhibition is dependent on p53, as it is impaired in p53-knockdown or p53-deficient cells.
  • DNA damage upregulates both E2F1 and p53, leading to E2F1-mediated MDM2 inhibition and p53 accumulation.
  • E2F1-induced MDM2 inhibition promotes E2F1-driven apoptosis.

Conclusions:

  • E2F1 regulates the MDM2-p53 pathway by suppressing MDM2 promoter activity in a p53-dependent manner.
  • This mechanism plays a role in p53 accumulation and apoptosis induction, particularly after DNA damage.
  • E2F1's regulation of MDM2 is a key event in controlling cell fate decisions.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...